Skip to main content

That's Odd: Bearish MYGN Analysts See 15.82% Upside

Analyst ratings can sometimes be complicated, and we here at ETF Channel have noticed a bit of a paradox with Myriad Genetics, Inc. (MYGN)..
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.